LABOCANNA S.A. ZY-10 (9Y2) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has a cash flow conversion efficiency ratio of -0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-258.12K ≈ $-301.77K USD) by net assets (€6.05 Million ≈ $7.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LABOCANNA S.A. ZY-10 balance sheet quality to measure how much of total assets are equity-financed.
LABOCANNA S.A. ZY-10 - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how LABOCANNA S.A. ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LABOCANNA S.A. ZY-10 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
LABOCANNA S.A. ZY-10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
-0.157x |
|
Yolo SA
WAR:YOL
|
0.005x |
|
Oriental Rise Holdings Limited Ordinary Shares
NASDAQ:ORIS
|
0.012x |
|
Network Media Group Inc
V:NTE
|
0.082x |
|
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA
|
119.987x |
|
Eco Animal Health Group Plc
LSE:EAH
|
-0.011x |
|
Enveric Biosciences Inc
NASDAQ:ENVB
|
-0.600x |
|
Maven Income And Growth Vct Plc
LSE:MIG1
|
-0.003x |
Annual Cash Flow Conversion Efficiency for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual cash flow conversion efficiency of LABOCANNA S.A. ZY-10 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market value of LABOCANNA S.A. ZY-10.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €6.05 Million ≈ $7.07 Million |
€-444.75K ≈ $-519.96K |
-0.074x | +50.41% |
| 2024-12-31 | €6.40 Million ≈ $7.48 Million |
€-949.69K ≈ $-1.11 Million |
-0.148x | +3.94% |
| 2023-12-31 | €7.01 Million ≈ $8.19 Million |
€-1.08 Million ≈ $-1.27 Million |
-0.154x | -310.60% |
| 2022-12-31 | €7.61 Million ≈ $8.89 Million |
€-286.11K ≈ $-334.49K |
-0.038x | -- |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporat… Read more